Lumabang, Jumilyn D.

HRN: 21-37-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFUROXIME 1.5GM (VIAL)
05/28/2022
05/28/2022
IV
1.5gm
Loading Dose
Prophylaxis For Elective Repeat CS
Waiting Final Action 
05/28/2022
CEFUROXIME 500MG (TAB)
05/28/2022
06/03/2022
ORAL
500mg/tab
BID
S/P Repeat LSTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: